AIM ImmunoTech Heads Into Monday Print Already Battered
AIM ImmunoTech arrives at its May 18 earnings event in a deeply compromised technical state — the stock has fallen 56% over the past month to $0.253, and Q1 results released late Friday only deepened the concern, with…